Illumina, Inc.: Latest Research at ESMO Congress 2022 Showcases the Impact of Comprehensive Genomic Profiling for Cancer Patients

Presentations will include evidence on how genomic signatures and next-generation sequencing can improve the care of patients with cancer SAN DIEGO, Sept. 5, 2022 /PRNewswire/ -- Illumina

Related Keywords

Florida ,United States ,Norway ,Paris ,France General ,France ,Utrecht ,Netherlands ,Munich ,Bayern ,Germany ,Norwegian ,Dutch ,Adi Raval ,Phil Febbo ,Bayer Vitrakvi ,Instagram ,Linkedin ,European Society Of Medical Oncology ,Twitter ,Allegheny Health Network ,Hartwig Medical Foundation ,Nasdaq ,Technical University Of Munich ,University Medical Center Utrecht ,Youtube ,Prnewswire Illumina Inc ,Facebook ,Institute Of Pathology ,Netherlands Cancer Institute ,Florida Cancer Specialists Research Institute ,European Society ,Medical Oncology ,Trusight Oncology ,Technical University ,Florida Cancer Specialists ,Illumina Supported Dutch ,Trusight Oncology Comprehensive ,Illumina ,Latest ,Research ,Osmo ,Congress ,022 ,Howcases ,Impact ,Comprehensive ,Enomic ,Profiling ,Dancer ,Patients ,